alexa Cetuximab is effective, but more toxic than reported in the Bonner trial.


Otolaryngology: Open Access

Author(s): Lord HK, Junor E, Ironside J

Abstract Share this page

This article was published in Clin Oncol (R Coll Radiol) and referenced in Otolaryngology: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version